Paradigm Medical Industries Inc.
2355 South 1070 West
Salt Lake City,
UT 84119
United States - Map
Phone: 801-977-8970
Fax: 801-977-8973
Web Site: http://www.paradigm-medical.com
| Paradigm Medical Industries, Inc. develops, manufactures, sources, markets, and sells ophthalmic surgical and diagnostic instrumentation and related accessories, including disposable products. The companys products include P2200 and P2500 pachymetric analyzer; P2000 A-scan biometric ultrasound analyzer; P37, P37-II, P2700, and P3700 A/B scan ocular ultrasound diagnostic product; P40 UBM ultrasound biomicroscope; P45 UBM and P60 UBM ultrasound biomicroscope; BFA ocular blood flow analyzer and disposables; CT 200 corneal topography system; LD 400 autoperimetry system; TKS 5000 autoperimetry system; and glaid ocular electrophysiology device. Its products also comprise Precisionist Thirty Thousand, ocular surgery workstation with surgical equipment and disposables, and Photon laser products. The company markets its products to ophthalmologists, optometrists, universities, and clinics through direct sales representatives, independent sales organizations, and ophthalmic product distributors in the United States, as well as through a network of ophthalmic and medical product distributors internationally. Paradigm Medical Industries was founded in 1989 and is based in Salt Lake City, Utah. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Steven Davis , 61
Pres, Principal Exec. officer, Principal Financial Officer, Principal Accounting Officer and Treasurer |
$
20.00K | N/A | Mr. Julio C. Maximo ,
VP of Operations |
N/A
| N/A | Mr. Rudolph Schneid ,
Managing Director of European Operations |
N/A
| N/A | Mr. Michael Keane ,
Director of Global Sales |
N/A
| N/A | Ms. Deborah Petric ,
Director of Regulatory Affairs & Quality Assurance |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.28% Nasdaq 
0.0001 (3.85%) 
Profile
